AMRI buys Hyaluron to enter prefilled syringe market
AMRI has acquired Hyaluron for $27m (€22m) to enter the prefilled syringe market and expand the customer base for its existing operations.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs